Cancer research meets tick vectors for infectious diseases

Lancet Infect Dis. 2014 Oct;14(10):916-7. doi: 10.1016/S1473-3099(14)70902-8.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Arachnid Vectors / immunology*
  • Cetuximab
  • Humans
  • Immunoglobulin E / blood*
  • Neoplasms / drug therapy
  • Neoplasms / immunology*
  • Tick Infestations / immunology
  • Tick-Borne Diseases / immunology*
  • Ticks / immunology*
  • United States

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Immunoglobulin E
  • Cetuximab